{"id":"https://openalex.org/W2014501359","doi":"https://doi.org/10.1097/cco.0b013e3282f31d6f","title":"Restoration of p53 to limit tumor growth","display_name":"Restoration of p53 to limit tumor growth","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2014501359","doi":"https://doi.org/10.1097/cco.0b013e3282f31d6f","mag":"2014501359","pmid":"https://pubmed.ncbi.nlm.nih.gov/18043262"},"language":"en","primary_location":{"id":"doi:10.1097/cco.0b013e3282f31d6f","doi":"https://doi.org/10.1097/cco.0b013e3282f31d6f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cco.0b013e3282f31d6f","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2014501359"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028849312","display_name":"Wenge Wang","orcid":"https://orcid.org/0000-0001-9509-6735","observed_orcids":["https://orcid.org/0000-0001-9509-6735"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wenge Wang","raw_affiliation_strings":["Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA","Departments of Medicine, Genetics, Pharmacology, and Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Departments of Medicine, Genetics, Pharmacology, and Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075201353","display_name":"Wafik S. El\u2010Deiry","orcid":"https://orcid.org/0000-0002-9577-8266","observed_orcids":["https://orcid.org/0000-0002-9577-8266"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Wafik S El-Deiry","raw_affiliation_strings":["Departments of Medicine, Genetics, Pharmacology, and Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA","to Wafik S. El-Deiry, MD, PhD, University of Pennsylvania School of Medicine, 415 Curie Blvd., CRB 437A, Philadelphia, PA 19104, USA Tel: +1 215 898 9015; fax: +1 215 573 9139; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +1 215 573 9139","to Wafik S. El-Deiry, MD, PhD, University of Pennsylvania School of Medicine, 415 Curie Blvd., CRB 437A, Philadelphia, PA 19104, USA Tel: +1 215 898 9015"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine, Genetics, Pharmacology, and Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"to Wafik S. El-Deiry, MD, PhD, University of Pennsylvania School of Medicine, 415 Curie Blvd., CRB 437A, Philadelphia, PA 19104, USA Tel: +1 215 898 9015; fax: +1 215 573 9139; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 215 573 9139","institution_ids":[]},{"raw_affiliation_string":"to Wafik S. El-Deiry, MD, PhD, University of Pennsylvania School of Medicine, 415 Curie Blvd., CRB 437A, Philadelphia, PA 19104, USA Tel: +1 215 898 9015","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075201353"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":2.1529,"has_fulltext":false,"cited_by_count":120,"citation_normalized_percentile":{"value":0.89851024,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"20","issue":"1","first_page":"90","last_page":"96"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p53-restoration","display_name":"p53 restoration","score":0.9340000152587891},{"id":"https://openalex.org/keywords/mutant-p53","display_name":"mutant p53","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cp-31398","display_name":"CP-31398","score":0.8610000014305115},{"id":"https://openalex.org/keywords/prima-1","display_name":"PRIMA-1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/ellipticine","display_name":"ellipticine","score":0.996999979019165},{"id":"https://openalex.org/keywords/nutlin","display_name":"nutlin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/mdm2","display_name":"MDM2","score":0.9079999923706055},{"id":"https://openalex.org/keywords/p53-family","display_name":"p53 family","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.7239999771118164},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8930000066757202},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.7576390504837036},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7057284116744995},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6402763724327087},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.6278453469276428},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5844717621803284},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5794773101806641},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5230967998504639},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4907478094100952},{"id":"https://openalex.org/C207583985","wikidata":"https://www.wikidata.org/wiki/Q128723","display_name":"Wild type","level":4,"score":0.4800758957862854},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4772772192955017},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.4734330177307129},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4607125222682953},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4549599885940552},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33776843547821045},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2775609493255615},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13426914811134338},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12599217891693115},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11184245347976685}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001372","descriptor_name":"Aza Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001372","descriptor_name":"Aza Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004611","descriptor_name":"Ellipticines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004611","descriptor_name":"Ellipticines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016158","descriptor_name":"Genes, p53","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cco.0b013e3282f31d6f","doi":"https://doi.org/10.1097/cco.0b013e3282f31d6f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cco.0b013e3282f31d6f","pdf_url":null,"source":{"id":"https://openalex.org/S179395531","display_name":"Current Opinion in Oncology","issn_l":"1040-8746","issn":["1040-8746","1080-8140","1531-703X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Oncology","raw_type":"journal-article"},{"id":"pmid:18043262","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18043262","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":75,"referenced_works":["https://openalex.org/W75894761","https://openalex.org/W133702455","https://openalex.org/W165254100","https://openalex.org/W172347017","https://openalex.org/W1482923899","https://openalex.org/W1516887093","https://openalex.org/W1531240647","https://openalex.org/W1534987406","https://openalex.org/W1539294572","https://openalex.org/W1556144459","https://openalex.org/W1600706591","https://openalex.org/W1650797637","https://openalex.org/W1852079846","https://openalex.org/W1966292443","https://openalex.org/W1967710981","https://openalex.org/W1967822571","https://openalex.org/W1969044026","https://openalex.org/W1971274526","https://openalex.org/W1971357333","https://openalex.org/W1975713926","https://openalex.org/W1985064409","https://openalex.org/W1992166423","https://openalex.org/W1993864973","https://openalex.org/W1994852323","https://openalex.org/W1994949503","https://openalex.org/W1996649572","https://openalex.org/W1998559412","https://openalex.org/W2001781880","https://openalex.org/W2002292653","https://openalex.org/W2004706142","https://openalex.org/W2005013681","https://openalex.org/W2006313701","https://openalex.org/W2008220860","https://openalex.org/W2008798771","https://openalex.org/W2010045481","https://openalex.org/W2010370535","https://openalex.org/W2014075879","https://openalex.org/W2014938226","https://openalex.org/W2026060163","https://openalex.org/W2026774897","https://openalex.org/W2042923408","https://openalex.org/W2048362873","https://openalex.org/W2049137769","https://openalex.org/W2050745715","https://openalex.org/W2054197118","https://openalex.org/W2058769115","https://openalex.org/W2060972565","https://openalex.org/W2061831020","https://openalex.org/W2064850779","https://openalex.org/W2072706757","https://openalex.org/W2072755638","https://openalex.org/W2077301074","https://openalex.org/W2078242867","https://openalex.org/W2090471601","https://openalex.org/W2092291840","https://openalex.org/W2092902276","https://openalex.org/W2097933346","https://openalex.org/W2109483078","https://openalex.org/W2116914505","https://openalex.org/W2120878737","https://openalex.org/W2124570122","https://openalex.org/W2135192417","https://openalex.org/W2135471298","https://openalex.org/W2141375360","https://openalex.org/W2141823032","https://openalex.org/W2146882135","https://openalex.org/W2159849226","https://openalex.org/W2160863389","https://openalex.org/W2400514435","https://openalex.org/W6603045130","https://openalex.org/W6632355377","https://openalex.org/W6633346548","https://openalex.org/W6636064463","https://openalex.org/W6676619299","https://openalex.org/W6680576708"],"related_works":["https://openalex.org/W2009871049","https://openalex.org/W2069526661","https://openalex.org/W2225251024","https://openalex.org/W1516887093","https://openalex.org/W2156119613","https://openalex.org/W2064508063","https://openalex.org/W2084103863","https://openalex.org/W1019097120","https://openalex.org/W4389780842","https://openalex.org/W2075505867"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"p53":[3,35,55,67,114,122,134,145,161],"mutation":[4],"occurs":[5],"in":[6,57,135],"over":[7],"half":[8],"of":[9,26,54,133,144,150,160],"all":[10,152],"human":[11,58,153],"tumors.":[12,154],"Among":[13],"the":[14,24,49,77,83,87],"remaining":[15],"tumors,":[16],"although":[17],"they":[18],"may":[19],"process":[20],"a":[21,38,148,168],"wild-type":[22,88,113],"p53,":[23],"pathways":[25],"p53-induced":[27],"cell-cycle":[28],"arrest":[29],"and":[30,95,128,138,165],"apoptosis":[31],"are":[32],"deficient.":[33],"Therefore,":[34],"serves":[36],"as":[37,131,167],"unique":[39],"molecular":[40],"target":[41],"for":[42,60,68],"cancer":[43,69],"therapy.":[44,63],"This":[45],"review":[46],"focuses":[47],"on":[48],"current":[50],"progress":[51],"regarding":[52],"restoration":[53],"function":[56,146,162],"tumors":[59],"molecularly":[61],"targeted":[62],"RECENT":[64],"FINDINGS:":[65],"Targeting":[66],"therapy":[70],"has":[71],"been":[72],"intensively":[73],"pursued.":[74],"CP-31398":[75],"was":[76,109],"first":[78],"small":[79],"molecule":[80],"identified":[81],"with":[82],"ability":[84],"to":[85,90,99,102,111],"restore":[86],"conformation":[89],"mutant":[91,104],"p53.":[92],"Subsequently,":[93],"PRIMA-1":[94],"ellipticine":[96],"were":[97],"found":[98],"be":[100,126],"able":[101],"induce":[103,139],"p53-dependent":[105],"cell":[106,140],"death.":[107,141],"Nutlin":[108],"developed":[110],"rescue":[112],"from":[115],"degradation":[116],"mediated":[117],"by":[118],"MDM2.":[119],"More":[120],"recently,":[121],"family":[123],"members":[124],"can":[125],"activated":[127],"therefore":[129],"serve":[130],"substitutes":[132],"tumor":[136],"cells":[137],"SUMMARY:":[142],"Loss":[143],"is":[147,163],"characteristic":[149],"almost":[151],"Recent":[155],"advances":[156],"demonstrate":[157],"that":[158],"reconstitution":[159],"possible":[164],"practical":[166],"promising":[169],"antitumor":[170],"strategy.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2014501359","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
